The influx of pricing data flooding the market as a result of the CMS Price Transparency Rule has opened the door on a whole new world of competitive insights for healthcare providers. However, a lack of standardization has also introduced the potential for confusion and inaccurate conclusions when the data is not approached with caution.

In the October 2023 issue of HFM Magazine, Panacea’s Govi Goyal, President of Financial Services, and Fred Stodolak, Chairman of the Board, discuss the findings of Panacea’s recent study demonstrating the pitfalls to consider when using machine-readable file data in comparative benchmarking.

Download the study to find out how your organization stands to benefit from existing negotiated rate data—and learn how to recognize misleading comparisons.